HCA HCA Healthcare, Inc.

CIK 0000860730 25 ready 8-Ks latest April 30, 2026, 7:59 PM ET RSS · JSON

Activity: QUIET 0 filings / 30d vs 1 baseline

Ready 8-Ks 25

Latest filing April 30, 2026, 7:59 PM ET

Top materiality 0.85

Event mix debt ×10 · earnings ×9 · other_material ×3

Sentiment 9 pos · 0 neg · 16 neu

Latest earnings reported 2026-Q1

Executive change recent →

Recent 8-K filings for HCA

Highest-materiality recent filing

HCA Healthcare Q4 EPS $8.14 (up 44.6%), revenue $19.5B, $10B buyback authorized

January 27, 2026, 6:59 PM ET earnings materiality 0.85 positive item 2.02 item 7.01 item 8.01 item 9.01

Q4 revenue $19.513B (+6.7% YoY); net income $1.878B (+30.6%); adjusted EBITDA $4.114B (+10.8%).
Diluted EPS $8.14 (+44.6%), adjusted EPS $8.01 (+28.8%); same-facility admissions +2.4%, equivalent admissions +2.5%.

Read filing →

April 30, 2026, 7:59 PM ET debt materiality 0.60 neutral item 1.01 item 2.03 item 8.01 item 9.01 ◈ Material Agreements

HCA Inc. issues $3B in senior notes across three tranches maturing 2031-2036

Issued $1B of 4.700% notes due 2031, $750M of 5.000% notes due 2033, and $1.25B of 5.300% notes due 2036.
April 24, 2026, 7:59 PM ET earnings materiality 0.65 positive item 2.02 item 7.01 item 8.01 item 9.01 ◈ Earnings Releases

HCA Q1 revenue up 4.3% to $19.1B; EPS rises 10.9% to $7.15; declares $0.78 dividend

Revenues $19.109B, net income $1.620B (+0.6% YoY); diluted EPS $7.15 (+10.9% YoY).
January 27, 2026, 6:59 PM ET earnings materiality 0.85 positive item 2.02 item 7.01 item 8.01 item 9.01

HCA Healthcare Q4 EPS $8.14 (up 44.6%), revenue $19.5B, $10B buyback authorized

Q4 revenue $19.513B (+6.7% YoY); net income $1.878B (+30.6%); adjusted EBITDA $4.114B (+10.8%).
October 31, 2025, 7:59 PM ET debt materiality 0.60 neutral item 1.01 item 2.03 item 8.01 item 9.01 ◈ Debt Financings

HCA issues $3.25B senior notes: 4.30% 2030, 4.60% 2032, 4.90% 2035, 5.70% 2055

$500M 4.30% notes due 2030, $1B 4.60% due 2032, $1B 4.90% due 2035, $750M 5.70% due 2055.
October 27, 2025, 7:59 PM ET debt materiality 0.65 neutral item 8.01 item 9.01

HCA subsidiary proposes senior notes offering, plans to redeem $1.5B 5.875% notes due 2026

HCA Inc. proposes public offering of senior unsecured notes; terms (maturity, rate, amount) to be set at pricing.
October 24, 2025, 7:59 PM ET earnings materiality 0.85 positive item 2.02 item 7.01 item 8.01 item 9.01

HCA Healthcare Q3 EPS $6.96, revenue $19.2B, raises 2025 guidance

Diluted EPS $6.96 (up 42.6% YoY); net income $1.643B (up 29.4%).
July 25, 2025, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 7.01 item 8.01 item 9.01

HCA Q2 revenue $18.6B (+6.4%), EPS $6.83 (+23.5%); raises 2025 guidance

Revenue $18.605B (+6.4% YoY); net income $1.653B (+13.1% YoY).
April 25, 2025, 7:59 PM ET earnings materiality 0.80 positive item 2.02 item 7.01 item 8.01 item 9.01

HCA Healthcare Q1 revenue $18.3B, EPS $6.45, adjusted EBITDA $3.73B, reaffirms guidance

Revenue $18.321B (+5.7% YoY); net income $1.610B, diluted EPS $6.45 (vs $5.93 prior year).
February 20, 2025, 6:59 PM ET debt materiality 0.60 neutral item 1.01 item 1.02 item 2.03 item 9.01

HCA enters $8.0B unsecured revolver, terminates secured credit facilities

New $8.0B senior unsecured revolving credit facility with 5-year maturity dated Feb 20, 2025.
February 18, 2025, 6:59 PM ET debt materiality 0.65 neutral item 8.01 item 9.01

HCA Inc. proposes public offering of senior notes; plans $8B unsecured credit facility to replace secured facilities

HCA subsidiary HCA Inc. proposes offering of senior notes; final terms (maturity, rate, amount) depend on market conditions.
January 24, 2025, 6:59 PM ET earnings materiality 0.75 positive item 2.02 item 7.01 item 8.01 item 9.01

HCA Q4 revenue $18.3B, EPS $5.63; 2025 EPS guidance $24.05-$25.85; $10B buyback authorized

Q4 revenue $18.285B (+5.7% YoY); net income $1.438B ($5.63 diluted EPS) vs $1.607B ($5.93) in 4Q23; includes $0.60/sh hurricane impact.
October 25, 2024, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 7.01 item 8.01 item 9.01

HCA Healthcare Q3 2024 revenue $17.49B, EPS $4.88; reaffirms FY guidance but sees lower half due to hurricanes

Revenue $17.487B (up 7.9% YoY), net income $1.270B (up 17.7%), diluted EPS $4.88 vs $3.91.
August 12, 2024, 7:59 PM ET debt materiality 0.60 neutral item 1.01 item 2.03 item 9.01

HCA Healthcare issues $3B in senior notes across three tranches with rates 5.45%-5.95%

$3B total: $750M 5.45% notes due 2031 (now $1.75B total), $1.25B 5.45% notes due 2034, $1B 5.95% notes due 2054.
July 23, 2024, 7:59 PM ET earnings materiality 0.85 positive item 2.02 item 7.01 item 8.01 item 9.01

HCA Q2 2024 rev $17.49B, EPS $5.53, raises FY guidance

Revenue $17.492B (+10.3% YoY); net income $1.461B ($5.53 diluted EPS) vs $1.193B ($4.29).
April 30, 2024, 7:59 PM ET leadership materiality 0.65 neutral item 5.02 item 5.07 ◈ executive_change ×2

HCA Healthcare CFO William Rutherford to retire May 1; Christopher Wyatt named principal accounting officer

William B. Rutherford retires as EVP/CFO effective May 1, 2024; Christopher Wyatt succeeds as principal accounting officer.
April 26, 2024, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 7.01 item 8.01 item 9.01 ◈ Earnings Releases

HCA Q1 revenue up 11% to $17.34B, EPS $5.93; reaffirms FY guidance

Revenue $17.339B (+11.2% YoY); net income $1.591B ($5.93 diluted EPS) vs $1.363B ($4.85).

Executive changes

Departed

Meg G. Crofton

Director

HCA · HCA Healthcare, Inc.

Filed: February 24, 2025, 6:59 PM ET

Retirement of Meg G. Crofton from the

Departed

William B. Rutherford

Executive Vice President, Chief Financial Officer, principal financial officer and principal accounting officer

HCA · HCA Healthcare, Inc.

Effective: 2024-05-01
Successor: Christopher F. Wyatt
Filed: April 30, 2024, 7:59 PM ET

As previously announced, William B. Rutherford, HCA Healthcare, Inc.’s (the “Company’s”) Executive Vice President, Chief Financial Officer, principal financial officer and principal accounting officer notified the Company of his intent to retire, effective May 1, 2024.

Appointed

Christopher F. Wyatt

Senior Vice President and Controller

HCA · HCA Healthcare, Inc.

Effective: 2024-05-01
Filed: April 30, 2024, 7:59 PM ET

In conjunction with Mr. Rutherford’s retirement, Christopher F. Wyatt, age 47, will succeed Mr. Rutherford as principal accounting officer, effective May 1, 2024.

Earnings & guidance

2026-Q1 EPS reported $7.15 filing →

Materiality & sentiment trend

Max materiality 0.85 · Median 0.60 · Most common event debt

9 positive 0 negative 16 neutral

source · HCA on sec.gov